Results 261 to 270 of about 19,291,811 (296)

Thimerosal positivities

Contact Dermatitis, 1996
B, Santucci, C, Cannistraci, E, Camera, A, Cristaudo, M, Picardo   +4 more
openaire   +2 more sources

Pili in Gram-positive pathogens

Nature Reviews Microbiology, 2006
Rino Rappuoli, Guido Grandi
exaly  

positive position

2014
openaire   +1 more source

HER2-positive breast cancer

Lancet, The, 2017
Sibylle Loibl, Luca Gianni
exaly  

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Lancet, The, 2016
Roy S Herbst, Paul Baas, Dong-Wan Kim
exaly  

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2020
Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas   +2 more
exaly  

Pseudo positive, pseudo positive negative, pseudo positive positive negative, and pseudo pseudo positive positive negative positive margins in dermatopathology.

Skinmed, 2013
Brian, Lee, Muriel W, Lambert, Chinmoy, Bhate, Joseph, Kamelgard, W Clark, Lambert   +4 more
openaire   +1 more source

Positive media

British Dental Journal, 2022
openaire   +2 more sources

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Lancet, The, 2010
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova   +2 more
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
Ruth M O'regan
exaly